Master Your Short Game and Long-Term Pharmacy Strategy at DealMAX.
April 7 – 9, 2025 | ARIA Resort & Casino, Las Vegas
At DealMAX 2025, RxBenefits is helping middle-market M&A professionals improve EBITDA by generating pharmacy savings and increasing cost predictability – with the added bonus of a skills test on the putting green.
Pharmacy is one of the biggest unmanaged cost centers in PortCos.
- U.S. prescription drug spending surged 11.4% to $449.7 billion last year
- Just 13% of employees drive 90% of pharmacy costs, due to ultra-high-cost medications
- Most firms are overspending by up to 35% without realizing it
Join us daily at the putting green in the main hall for:
- A putt-off tournament, where the winner takes home a Scotty Cameron Super Select Newport 2 putter
- Insights from our Private Equity experts on how to eliminate pharmacy overspend and improve PortCo valuations
Want to dive deeper?
Schedule a quick one-on-one meeting with our experts for a more in-depth discussion on improving EBITDA across your portfolio, and watch our GrowthTV episode to learn how pharmacy costs are impacting middle-market M&A.
To prepare for the conversation, we also encourage you to download our PE Pharmacy Solutions Overview.
